Clinical Trial Update: Prevenar13 Drug Use Investigation - Adults Aged 65 Years or Older-

View source ↗

Summary

Clinical trial update for Prevenar13 in adults aged 65 and older; study status completed with results posted in 2019.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pneumococcal Disease

Drugs mentioned

• Prevenar 13 (Pneumococcal conjugate vaccine (13-valent))

Snippet

Sponsor: Pfizer | Conditions: Adult Not Younger Than 65 Years | Status: COMPLETED | Results posted: 2019-02-28